Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENTA | ACRV | NKTR | ||
| Company | Enanta Pharmaceutica | Acrivon Therapeutics Inc | Nektar Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.41 | 6.61 | 1.0700 | ||
| High | 9.69 | 7.21 | 1.1200 | ||
| Low | 8.89 | 6.61 | 1.0700 | ||
| Last | 9.01 | 7.16 | 1.0900 | ||
| Change | -0.33 | +0.61 | +0.0400 | ||
| % Change | -3.53% | +9.31% | +3.81% | ||
| Volume | 205,000 | 84,300 | 2,480,700 | ||
| 20-Day Average Volume | 169,000 | 48,675 | 2,106,625 | ||
| Previous Close | 9.34 | 6.55 | 1.0500 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.44 | 7.62 | 1.2120 | ||
| 20-Day Raw Stochastic | 9.32% | 39.93% | 22.56% | ||
| 20-Day Relative Strength | 31.20% | 45.76% | 41.57% | ||
| Weighted Alpha | -30.01 | -11.75 | +51.22 | ||
| Today's Opinion | 100% Sell | 40% Sell | 72% Sell | ||
| Previous Opinion | 100% Sell | 40% Sell | 72% Sell | ||
| Last Month's Opinion | 72% Sell | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.85% since 11/18/24 | +14.19% since 11/18/24 | +5.83% since 11/18/24 | ||
| Low | 8.72 on 11/21/24 | 6.11 on 11/19/24 | 0.9793 on 11/21/24 | ||
| High | 9.69 on 11/25/24 | 7.21 on 11/25/24 | 1.1200 on 11/25/24 | ||
| 1-Month | |||||
| %Chg | -22.86% since 10/25/24 | -10.05% since 10/25/24 | -17.42% since 10/25/24 | ||
| Low | 8.72 on 11/21/24 | 6.11 on 11/19/24 | 0.9793 on 11/21/24 | ||
| High | 12.09 on 10/28/24 | 8.74 on 11/07/24 | 1.4700 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | -31.17% since 08/23/24 | -23.50% since 08/23/24 | -19.26% since 08/23/24 | ||
| Low | 8.72 on 11/21/24 | 6.11 on 11/19/24 | 0.9793 on 11/21/24 | ||
| High | 13.43 on 08/29/24 | 10.16 on 08/30/24 | 1.4900 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | -25.10% since 05/24/24 | -9.94% since 05/24/24 | -33.54% since 05/24/24 | ||
| Low | 8.72 on 11/21/24 | 5.50 on 06/28/24 | 0.9793 on 11/21/24 | ||
| High | 17.24 on 07/15/24 | 10.16 on 08/30/24 | 1.7100 on 05/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 197,905 | 203,941 | 193,681 | ||
| Shares Outstanding, K | 21,189 | 31,136 | 184,458 | ||
| Annual Sales | 79,200,000 | 0 | 90,120,000 | ||
| Annual Net Income | -133,820,000 | -60,390,000 | -276,060,000 | ||
| Last Quarter Sales | 17,970,000 | 0 | 24,120,000 | ||
| Last Quarter Net Income | -22,660,000 | -22,440,000 | -37,060,000 | ||
| 60-Month Beta | 0.56 | 0.66 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.07 on 08/05/24 | -0.59 on 11/13/24 | -0.18 on 11/07/24 | ||
| Latest Earnings Date | 11/25/24 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||